Randomised controlled trial of a very brief nurse-delivered intervention followed by a digital intervention to support medication adherence and reduce blood pressure in people prescribed treatment for hypertension in primary care: protocol for the Programme on Adherence to Medication (PAM) trial
Open Access
- 25 February 2026
- journal article
- research article
- Published by National Institute for Health and Care Research in NIHR Open Research
- Vol. 6, 18
Abstract
Introduction Hypertension is a global health challenge accounting for 8.5 million deaths worldwide despite the availability of low-cost pharmaceutical treatment. About 14.9% of people (9.9 million) registered with primary care practices in England and Wales are prescribed medication for hypertension. However, many patients with hypertension and associated conditions do not take their medications as prescribed. Non-adherence to antihypertensive medication is associated with increased risk of suboptimal blood pressure (BP) control, complications and all-cause mortality, and increased healthcare costs. The Programme on Adherence to Medication (PAM) trial will estimate the effectiveness and cost-effectiveness of a medication adherence intervention in patients prescribed medication for hypertension with poorly controlled blood pressure in primary care. Methods A two-arm multicentre individually randomised controlled parallel group superiority trial recruiting patients prescribed medication for hypertension with poorly controlled BP in primary care practices in England and Wales. The target sample size is 542. Participants in the Intervention group will receive a very brief intervention delivered remotely (by telephone or video call) by a practice nurse or healthcare assistant followed by a digital intervention (text messaging or smartphone app) in addition to usual care; control group participants will receive usual care alone. The primary outcome is systolic BP measured at 12 months. Medication adherence will be measured by chemical adherence testing of urine samples and self-report. An economic evaluation and a process evaluation will be undertaken. Ethics and dissemination The Cambridge East Independent Research Ethics Committee (REC reference 19/EE/0354), the Health Research Authority (HRA) and Health and Care Research Wales (HCRW) approved the trial. The findings will be disseminated to the scientific community, participating practitioners and patients, relevant patient groups and the public using a range of methods, including journal articles, conference presentations, newsletters and the Programme website. Trial registration number The UK’s Clinical Trial Registry ISRCTN82013652Keywords
Funding Information
- National Institute for Health and Care Research (RP-PG-0615-20013)
This publication has 64 references indexed in Scilit:
- Thematic Analysis2022
- Mobile Text Messaging and Adherence of Patients to Medication PrescriptionsJAMA Internal Medicine, 2016
- Intentional Non-Adherence to Medications by Older AdultsDrugs & Aging, 2014
- Physical Activity and the Prevention of HypertensionCurrent Hypertension Reports, 2013
- The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered Techniques: Building an International Consensus for the Reporting of Behavior Change InterventionsAnnals of Behavioral Medicine, 2013
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Adjusting for partially missing baseline measurements in randomized trialsStatistics in Medicine, 2004
- Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimationHealth Economics, 1997
- The theory of planned behaviorOrganizational Behavior and Human Decision Processes, 1991
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990